APA (7th ed.) Citation

TJ, H., L, C., & AS, K. (2026). Reforming Payment for Clinician-Administered Drugs - Most-Favored-Nation Pricing in Medicare Part B. The New England journal of medicine, 394(18), 1774. https://doi.org/10.1056/NEJMp2600417

Chicago Style (17th ed.) Citation

TJ, Hwang, Clemans-Cope L, and Kesselheim AS. "Reforming Payment for Clinician-Administered Drugs - Most-Favored-Nation Pricing in Medicare Part B." The New England Journal of Medicine 394, no. 18 (2026): 1774. https://doi.org/10.1056/NEJMp2600417.

MLA (9th ed.) Citation

TJ, Hwang, et al. "Reforming Payment for Clinician-Administered Drugs - Most-Favored-Nation Pricing in Medicare Part B." The New England Journal of Medicine, vol. 394, no. 18, 2026, p. 1774, https://doi.org/10.1056/NEJMp2600417.